日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A composite (18)F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)

一种基于 (18)F-FDG PET/CT 和 HER2 组织的复合生物标志物,用于预测 HER2 阳性乳腺癌对新辅助帕妥珠单抗和曲妥珠单抗的反应 (TBCRC026)

Hennessy, Maeve A; Cimino-Mathews, Ashley; Carter, Jodi M; Kachergus, Jennifer M; Ma, Yaohua; Leal, Jeffrey P; Solnes, Lilja B; Abramson, Vandana G; Carey, Lisa A; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C; Wahl, Richard L; Huang, Chiung-Yu; Stearns, Vered; Thompson, E Aubrey; Connolly, Roisin M

Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer

肿瘤微环境中单细胞和血管的空间结构可预测三阴性乳腺癌的临床结果

Mi, Haoyang; Varadhan, Ravi; Cimino-Mathews, Ashley M; Emens, Leisha A; Santa-Maria, Cesar A; Popel, Aleksander S

A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer

一项关于tremelimumab单药或联合olaparib治疗复发性上皮性卵巢癌的临床研究

Gaillard, Stéphanie; Verma, Neha; Berg, Maureen; Harrison, Jeanne; Huang, Peng; Leatherman, James M; Doucet, Michele; Sen, Rupashree; Suru, Aditya; Cai, Hongyan; Durham, Jennifer; Jelovac, Danijela; Cimino-Mathews, Ashley; Cherry, Christopher; Ganguly, Sudipto; Emens, Leisha A

A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.

一项针对伴或不伴有生殖系 BRCA 突变的转移性三阴性乳腺癌患者的 II 期试点研究,评估抗 PD-L1 药物 Durvalumab 和 PARP 抑制剂 Olaparib 的疗效。

Fujii Takeo, Cimino-Mathews Ashley, Lipkowitz Stanley, Lee Min-Jung, Nair Jayakumar, Solarz Britanny Brooke, Zimmer Alexandra, Redd Bernadette, Levy Elliot B, Rastogi Shraddha, Sato Nahoko, McCoy Ann, Steinberg Seth M, Lee Jung-Min

Breast schwannoma: review of entity and differential diagnosis

乳腺神经鞘瘤:疾病概述及鉴别诊断

Sanchez, Sandra Ixchel; Cimino-Mathews, Ashley

Incidental detection of rare metastatic basal cell carcinoma on screening mammography

在筛查性乳腺X线摄影中偶然发现罕见的转移性基底细胞癌

DiTommaso, Alexandra; Mangone, Ciera; Cimino-Mathews, Ashley; Panigrahi, Babita

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

肺癌新辅助治疗后病理反应与生存率的关系

Deutsch, Julie Stein; Cimino-Mathews, Ashley; Thompson, Elizabeth; Provencio, Mariano; Forde, Patrick M; Spicer, Jonathan; Girard, Nicolas; Wang, Daphne; Anders, Robert A; Gabrielson, Edward; Illei, Peter; Jedrych, Jaroslaw; Danilova, Ludmila; Sunshine, Joel; Kerr, Keith M; Tran, Mia; Bushong, Judith; Cai, Junliang; Devas, Vipul; Neely, Jaclyn; Balli, David; Cottrell, Tricia R; Baras, Alex S; Taube, Janis M

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

恩替诺特、纳武利尤单抗和伊匹木单抗治疗晚期 HER2 阴性乳腺癌女性:一项 Ib 期试验

Roussos Torres Evanthia T, Ho Won J, Danilova Ludmila, Tandurella Joseph A, Leatherman James, Rafie Christine, Wang Chenguang, Brufsky Adam, LoRusso Patricia, Chung Vincent, Yuan Yuan, Downs Melinda, O'Connor Ashley, Shin Sarah M, Hernandez Alexei, Engle Elizabeth L, Piekarz Richard, Streicher Howard, Talebi Zahra, Rudek Michelle A, Zhu Qingfeng, Anders Robert A, Cimino-Mathews Ashley, Fertig Elana J, Jaffee Elizabeth M, Stearns Vered, Connolly Roisin M

Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells

绘制乳腺肿瘤微环境图谱:邻近性分析揭示巨噬细胞亚型与转移起始癌细胞之间的空间关系

Grasset, Eloïse M; Deshpande, Atul; Lee, Jae W; Cho, Yeonju; Shin, Sarah M; Coyne, Erin M; Hernandez, Alexei; Yuan, Xuan; Zhang, Zhehao; Cimino-Mathews, Ashley; Ewald, Andrew J; Ho, Won Jin

Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI

术前乳腺MRI中与恶性乳腺癌肿块相邻的非肿块性强化的放射病理学相关性

Nguyen, Derek L; Lotfalla, Mira; Cimino-Mathews, Ashley; Habibi, Mehran; Ambinder, Emily B